Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type 1

Human Molecular Genetics

Volumn 11, Issue 4, 2002, Pages 347-357

  Koeller, David M ^a   Woontner, Michael ^b   Crnic, Linda S ^b   Kleinschmidt Demasters, Bette ^b   Stephens, Janet ^b   Hunt, Edgar L ^b   Goodman, Stephen I ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTARIC ACID; GLUTARIC ACID DERIVATIVE; GLUTARYL COENZYME A DEHYDROGENASE;

ACIDEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; BODY FLUID; BRAIN ATROPHY; BRAIN SPONGIOSIS; CAUDATE NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DYSKINESIA; DYSTONIA; ENZYME DEFICIENCY; GENE DELETION; GENE TARGETING; MACROCEPHALY; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PUTAMEN; SEQUENCE HOMOLOGY; WHITE MATTER;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE TARGETING; GLUTARATES; GLUTARYL-COA DEHYDROGENASE; HUMANS; MICE; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHENOTYPE;

ANIMALIA; SYLVIA;

EID: 0037084783     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mammalian metabolism of glutaric acid
2. Neuropathology in glutaric acidaemia type 1
3. Striatal degeneration and spongy myelinopathy in glutaric acidemia
4. Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1
5. Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia
6. Diagnosis and management of glutaric aciduria type I
7. Clinical course, early diagnosis, treatment and prevention of disease in glutaryl-CoA dehydrogenase deficiency
8. Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia I
9. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro
10. Glutaric aciduria type I: Pathomechanisms of neurodegeneration
11. Hypothesis: A role for quinolinic acid in the neuropathology of glutaric aciduria type I
12. Analysis of the expression of murine glutaryl-CoA dehydrogenase: In vitro and in vivo studies
13. Neurological abnormalities in a knock-in mouse model of Huntington's disease
14. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease
15. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease
16. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
17. Prepulse inhibition of the startle response in mice: Relationship to hearing loss and auditory system plasticity
18. Glutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically and biochemically distinct
19. Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations
20. Mice with mutations in the mahogany gene Atrn have cerebral spongiform changes
21. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
22. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies
23. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice